Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Consumer,Bevacizumab with lomustine,"High-grade glioma, relapsed or recurrent",Bevacizumab with lomustine,Recommended for decline,Community and Hospital,Oncology Agents and Immunosuppressants
